New computerized memory screening methods begin to move standardized memory health tests into the home and physician’s office. Screening for early, subtle signs of cognitive impairment becomes important as pharmaceutical companies shift focus to Alzheimer’s drug candidates that may prevent or slow buildup of amyloid protein in the brain.
MyBrainTest.org, a research and advisory service for the cognitive health and neurodiagnostic industry, has released a free Executive Summary report on current and emerging testing methods for early detection of Alzheimer’s disease, with a current focus on computerized memory assessment tools.
There are two important drivers for computerized memory assessments:
A $2.1+ Trillion Global Economic Cost of Dementia by 2050. In 2010 the worldwide cost of dementia was estimated at US$604 Billion, and this cost is expected to balloon to US$1.1 Trillion by 2030 and US $2.1 Trillion by 2050. The number of seniors (age 65+) is projected to be over 1.5 billion people by 2050 – dementia rates begin to rise sharply in this population group after age 75. Having reliable, easy to use tools to screen for memory and cognitive impairment will become increasingly important.
Rapid Advances in Technology Platforms. Tablet applications with secure wireless access to “big data” psychometric norms and reports are augmenting, and in some cases replacing traditional pencil and paper cognitive tests.
General pricing information, along with cognitive assessment test report samples from many of these products are included in the full report.
More information: Memory Test and Assessment Products